Cardiovascular
Pharmaceutical Market in India 2014
report highlights the analysis of the drivers and explains the factors for
growth of the industry. Increasing patient population, patent expiry of
blockbuster drugs, and introduction of newer and better drugs are the key
drivers of this market. Cardiovascular pharmaceuticals is one of the leading
therapeutic segments of the overall pharma industry and cardiovascular diseases
(CVDs) are the top causes of deaths worldwide.
Growing
incidences of cardiovascular diseases is helping the Indian market to grow and
large pharmaceutical companies are trying to launch new patented blockbuster
drugs to tackle the situation. Patented blockbuster drugs, after becoming
generic, present a huge opportunity for growth. Generic drugs increase the
affordability among patients, which helps in the growth of the market. The
increasing disposable income of people are also helping to boost the market
size. Some challenges faced by the
industry are the internal competition between large pharmaceutical companies
and competition from complementary and alternative medicines. Various
government initiatives have been undertaken to reduce the drug prices and
various tax reforms and control programs are promoting the growth of the market
as well.
Spanning
over 99 pages, “Cardiovascular Pharmaceuticals
Market in India 2014” report covering the Executive Summary, Macroeconomic
Indicators, Introduction, Market Overview, Drivers & Challenges, Government
Initiatives, Competitive Landscape, Recent Developments, Strategic
Recommendation, Appendix. This report Covered 16 Companies - AstraZeneca Pharma
India Ltd., Sanofi India Ltd., Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline
Pharmaceuticals Ltd., Lupin Ltd., Merck Ltd., Novartis India Ltd., Pfizer Ltd.,
Ranbaxy Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Torrent
Pharmaceutical Ltd., Bristol-Myers Squibb India Pvt. Ltd., Cadila
Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., USV Ltd.
Know more about this report
at
– http://mrr.cm/Zun
Find all Pharma and Healthcare
Reports at: http://www.marketresearchreports.com/pharma-healthcare
No comments:
Post a Comment
Note: only a member of this blog may post a comment.